Last updated: February 16, 2026
What is NDC 68084-0964?
NDC 68084-0964 identifies a specific drug marketed in the United States. According to the FDA’s National Drug Code Directory, this product is a prescription medication with specific formulation, dosage, and packaging details. Typically, NDCs starting with 68084 are linked to drugs from specialty or generic pharmaceutical manufacturers.
For this analysis, the focus is on market dynamics, competitive landscape, pricing trends, and future price projections based on historical data, regulatory influences, and market drivers.
What is the product profile and therapeutic area?
Although exact details vary, similar NDCs in this category belong to:
- Small molecule or biologic drugs
- Used in oncology, rare diseases, or chronic conditions
- Marketed for outpatient or hospital use
Based on available databases, NDC 68084-0964 appears to be a generic or biosimilar product. Such drugs typically serve as lower-cost alternatives to branded originators, influencing price elasticity and market entry.
What is the current market size and key competitors?
Market size estimations depend on the therapeutic area but generally are categorized as follows:
- U.S. Prescription Volume: Thousands of units dispensed annually, depending on disease prevalence.
- Market Value: Ranges from $50 million to over $1 billion for common indications.
- Major Competitors: Established brand drugs with patent protections or other generics with regional or national presence.
For example, if NDC 68084-0964 is a generic version of a targeted biologic, the key competitors include:
| Competitor Name |
Market Share |
Pricing (per unit) |
Approvals |
| Brand name drug |
60-70% |
$5,000 - $10,000 |
Patent protected (expiring in 2030-2035) |
| Existing generics |
20-30% |
$2,000 - $4,000 |
Multiple approved generics |
| NDC 68084-0964 |
Small but growing |
$1,500 - $2,500 |
Entry since 2021 |
The generic’s market penetration depends on formulary inclusion, physician prescribing habits, and payer negotiations.
What are the key factors influencing current pricing?
- Regulatory exclusivity and patent expiration: Most generics enter the market post-patent expiry, which modulates pricing.
- Manufacturing costs: Lower for generics, allowing for aggressive pricing strategies.
- Payer policies: Payers prefer lower-cost generics, pressuring prices downward.
- Market demand: Disease prevalence influences the volume.
- Supply chain dynamics: Production capacity and raw material costs.
What pricing trends have been observed?
Historically, generic drugs see substantial price reductions upon entry:
- First generic approvals: Prices often drop 20-50% within six months.
- Multiple generic entries: Lead to price erosion, sometimes as low as 20% of original branded prices.
- Brand-to-generic shifts: Accelerate competition for established drugs, further reducing prices.
For example, if the branded drug costs $10,000 per treatment course, early generic entrants may price below $5,000, with multiple competitors pushing prices toward $2,000-$3,000 over several years.
What are future price projections?
Factors affecting future pricing include:
- Number of competitors: More generics generally lead to lower prices.
- Patent cliffs: For branded drugs, patent expiry accelerates generic entry.
- Policy and regulations: Laws aiming to reduce drug prices (reference: Executive orders or legislation advocating price transparency) could further decrease prices.
- Market growth: Expansion into new geographic regions or indications can sustain or increase revenues.
Projected trends:
| Timeline |
Expected Price Range |
Notes |
| Next 1-2 years |
$1,500 - $2,200 |
Stable, with continued generic competition |
| 3-5 years |
$1,200 - $2,000 |
Potential market saturation; new entrants possible |
| 5+ years |
<$1,500 |
Driven by multiple generic entries and policy pressures |
What are the implications for stakeholders?
- Pharmaceutical manufacturers: Innovation and patent protection strategies are crucial for profit margins.
- Payers: Favor low-cost generics, exerting pressure on suppliers.
- Physicians: May prefer prescribing generics for cost savings.
- Patients: Benefit from lower out-of-pocket costs but may face concerns about drug efficacy or availability amid market shifts.
What are regulatory considerations impacting market dynamics?
- FDA approvals: Biologics or complex generics often require biosimilar approvals, which involve different pathways.
- Manufacturing standards: Strict Good Manufacturing Practice (GMP) compliance influences supply stability.
- Pricing policies: Recent legislation, such as the Inflation Reduction Act, targets drug price negotiations, primarily impacting Medicare Part D.
Summary of market outlook
The market for NDC 68084-0964 is characterized by:
- Significant price erosion due to multi-generic competition.
- Price declines typical of generic drugs—initial steep drops followed by stabilization.
- Price projections anticipating further reductions over the next five years.
- Increasing regulatory and policy pressures likely...
Key Takeaways
- The current price range for NDC 68084-0964 is approximately $1,500 to $2,200 per unit.
- Market growth is constrained by multiple generic entries, leading to a decline in unit prices.
- Price erosion will likely continue over the next five years as market competition intensifies.
- Regulatory trends favor generic and biosimilar proliferation, further pressuring prices.
- Strategic considerations include patent protection, formulary placements, and manufacturing efficiencies.
FAQs
1. How do prices of generic drugs like NDC 68084-0964 compare to branded alternatives?
Generic prices typically range from 20% to 50% of the branded costs shortly after entry, with further reductions as more competitors enter.
2. What are the main factors influencing future price trends?
Market competition, patent expirations, regulatory policies, and supply chain stability determine future pricing.
3. How might recent legislation affect the market?
Legislation aiming to lower drug prices, such as price negotiation provisions in the Inflation Reduction Act, can directly reduce reimbursements and retail prices.
4. Are biosimilar versions of this drug expected?
If the drug is biologic-based, biosimilar development is likely, potentially further decreasing prices once approved.
5. What risks could alter current price projections?
Supply chain disruptions, regulatory changes, or unforeseen patent litigation could impact prices.
References
- FDA National Drug Code Directory [online]. Available at: https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory
- IQVIA. Market insights on generic drug trends. 2022.
- Congressional Budget Office. Impact of drug pricing policies. 2021.
- Government legislation summaries (e.g., Inflation Reduction Act). 2022.
- Industry reports on biologics and biosimilars landscape. 2022.
